Navigation Links
OncoSec Releases Devices for Use in Clinical Trials
Date:10/5/2011

SAN DIEGO, Oct. 5, 2011 /PRNewswire/ -- OncoSec Medical Incorporated (OTCBB: ONCS), which is developing its advanced-stage OMS ElectroOncology™ therapies to treat solid tumor cancers, announced today that the OncoSec Medical System (OMS) devices have been qualified and released and are now ready for shipment to clinical sites in time for the upcoming OMS ElectroImmunotherapy™ clinical trials.

(Photo: http://photos.prnewswire.com/prnh/20111005/LA80865)

(Logo: http://photos.prnewswire.com/prnh/20110314/MM64943LOGO)

In March 2011 OncoSec acquired the rights to an electroporation delivery technology platform that can be used to efficiently deliver a chemotherapeutic or DNA-based cytokine agent for the treatment of solid tumors, which OncoSec has branded as the OncoSec Medical System (OMS). Since then, projects were initiated to establish engineering and manufacturing capabilities, as well as, transfer and update regulatory, design and manufacturing documentation, including implementing a new quality assurance system. Over the course of five months a manufacturing plan was executed to ensure that the devices acquired by OncoSec were safe and ready for use in clinical trials. The company now has inventory of OMS investigational devices adequate to support known and anticipated clinical study requirements well into 2013. OncoSec's current infrastructure and facility is designed to support manufacturing, assembly, testing, technical and regulatory support for multiple clinical trials in compliance with FDA and quality systems regulations.  The extent of OncoSec manufacturing operations allow the company to build and maintain the current device supply to support on-going and future clinical trials, scale up production as needed as well as design and develop a next generation OMS electroporation system
'/>"/>

SOURCE OncoSec Medical Incorporated
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. OncoSec Medical Licenses Non-DNA Vaccine Tumor Therapy Technology from Inovio Pharmaceuticals
2. Inovio Pharmaceuticals Licenses Non-DNA Vaccine Tumor Therapy Technology to OncoSec Medical
3. OncoSec Medical to Present at ROTH 23rd Annual Growth Stock Conference
4. OncoSec Medical Closes $1.1M Financing
5. OncoSec Medical Closes Purchase and License Agreement for Tumor Therapy Technology with Inovio Pharmaceuticals
6. OncoSec Medical Announces the Appointment of Dr. Anthony E. Maida, III, to Its Board of Directors
7. OncoSec Medical Appoints Engineering Leader
8. OncoSec Medical to Present at Industry and Investor Conferences
9. OncoSec Medical to Attend 6th Annual Fire, Ice and Beyond: The Future of Ablation Therapies Conference
10. OncoSec Announces Positive Results from Head & Neck and Breast Cancer Trials
11. Update: OncoSec Announces Positive Results From Head & Neck and Breast Cancer Trials
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... 2013  PENTAX Medical, a healthcare industry leader ... leader in ultrasound imaging, recently announced renewed collaborative ... further innovation in the development of Endoscopic Ultrasound ... and PENTAX Medical endoscopic portfolio have formed one ... systems. This agreement will continue to grow their ...
(Date:5/17/2013)... May 17, 2013  Boston Scientific Corporation (NYSE: ... annual EuroPCR Scientific Program May 21-24 in ... present a particularly rich and diversified set of data ... , M.D., global chief medical officer, Boston Scientific.  ... presented, including the NG PROMUS trial, which evaluated our ...
(Date:5/16/2013)... May 16, 2013  Today, the National Patient Advocate ... House of Representatives recently approved a bill that ... charging patients higher out-of-pocket fees for newer, more expensive ... which have more severe side-effects. However, the bill was ... which will continue to be a barrier to patients ...
Breaking Medicine Technology:PENTAX Medical And Hitachi-Aloka Medical Continue Joint Innovation And Global Leadership In Endoscopic Ultrasound Systems 2PENTAX Medical And Hitachi-Aloka Medical Continue Joint Innovation And Global Leadership In Endoscopic Ultrasound Systems 3Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 2Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 3Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 4Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 5Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 6Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 7Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 8National Patient Advocate Foundation Responds to N.C. State House Approval of Flawed Cancer Treatment Fairness Bill 2National Patient Advocate Foundation Responds to N.C. State House Approval of Flawed Cancer Treatment Fairness Bill 3
... 7, 2011 Reportlinker.com announces that a ... in its catalogue: ... 2011 http://www.reportlinker.com/p0284906/Immunotherapy-in-Oncology-Drug-Pipeline-Update-2011.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Biological_Therapy ... an attractive therapeutic addition, delivering treatment ...
... Sept. 6, 2011 MAP Pharmaceuticals, Inc. (Nasdaq: ... the following investor conferences in September: Stifel Nicolaus ... Boston UBS Global Life Sciences Conference Wednesday, September ... A live webcast of each event will be available on ...
Cached Medicine Technology:Immunotherapy in Oncology Drug Pipeline Update 2011 2Immunotherapy in Oncology Drug Pipeline Update 2011 3Immunotherapy in Oncology Drug Pipeline Update 2011 4Immunotherapy in Oncology Drug Pipeline Update 2011 5Immunotherapy in Oncology Drug Pipeline Update 2011 6Immunotherapy in Oncology Drug Pipeline Update 2011 7
(Date:5/18/2013)... 2013 Three new locations will be ... wellness centers and one therapeutic dispensary. Patient Appreciation Fair ... weekend of May 25th – May 27th, particularly honoring ... All events will take place from 11:00 ... Elements Therapeutic Dispensary , 10580 S. State Route 69, ...
(Date:5/17/2013)... (PRWEB) May 17, 2013 Orriant ... corporate wellness programs to businesses across the U.S. ... been achieved through rigorous infrastructure upgrades for their ... for employee interactions via voice and data. ... lower employee healthcare costs and take ...
(Date:5/17/2013)... 2013 Spring floods, summer droughts and ... gardeners who tend them. Help gardens recover from the ... each year. Myers suggests the following steps to ... Start by assessing the current condition of the landscape. ... harbor insect and disease organisms that can infest healthy ...
(Date:5/17/2013)... 2013 Degenerative changes to the area of ... with compression, known as the nucleus pulposus, has been demonstrated ... new study led by researchers at the Icahn School of ... journal PLOS ONE, reinforces the importance of diabetes in inducing ... is the first study to demonstrate that these changes can ...
(Date:5/17/2013)... Martinson-Nicholls new slip-resistant stair ... slip-resistant renovation tread used on steps that require ... staircase renovation projects, our treads and nosings deliver ... to compliment building designs. Bold Step is strong ... home stairs such as basement or deck steps. ...
Breaking Medicine News(10 mins):Health News:Elements Honors Medical Marijuana Patients at Elements Health and Wellness Centers and Elements Therapeutic Dispensary 2Health News:Elements Honors Medical Marijuana Patients at Elements Health and Wellness Centers and Elements Therapeutic Dispensary 3Health News:Elements Honors Medical Marijuana Patients at Elements Health and Wellness Centers and Elements Therapeutic Dispensary 4Health News:New Telecommunications Upgrade Provides More Capacity for National Corporate Wellness Programs offered by Orriant 2Health News:Garden Revival: Gardening Expert Melinda Myers Shares Tips for Helping Gardens Recover From Extreme Weather Conditions 2Health News:Garden Revival: Gardening Expert Melinda Myers Shares Tips for Helping Gardens Recover From Extreme Weather Conditions 3Health News:Degenerative Changes Identified in Spinal Discs and Reversed With Drug Cocktail In Diabetic Mice 2Health News:Degenerative Changes Identified in Spinal Discs and Reversed With Drug Cocktail In Diabetic Mice 3Health News:Degenerative Changes Identified in Spinal Discs and Reversed With Drug Cocktail In Diabetic Mice 4Health News:New Bold Step Renovation Stair Treads and Nosings from Martinson-Nicholls Add Slip Resistance to Stairs 2
... Relations, a leading brand-building public relations firm, announced it ... to promote MAQUET Inc.,s VARIOP operating room suite in ... of medical equipment and systems known for high quality, ... MAQUET has been installing VARIOP in hospitals ...
... High Purity Water is a critical ingredient in the ... for high quality water (HQW) is the single biggest ... market segment in the pharmaceutical sector. Frost & Sullivan,s ... water and wastewater management market in the European pharmaceutical ...
... Department of Orthopaedic Surgery, available for download as a PDF, details the ... ... 8, 2008 -- In 2008, 240,000 people in the United States of ... A new guide from Cleveland Clinic includes a multitude of conservative ...
... CINT, has joined the staff at the St. John-Clark ... Paul St. John, Randall Clark, Tracy Alan Jones, Brunella ... the rest of the clinic,s dream team. From ... by recruiting top therapists from across the country who ...
... precious metal tubing production capacity by 50% , ... ... Johnson Matthey Medical has announced the expansion of its Precious Metal ... Platinum-Iridium electrodes and marker bands. Precious metals - Platinum, in ...
... meant to limit minors, indoor tanning use have had ... of CANCER , a peer-reviewed journal of the ... are needed to reduce indoor tanning use in youth. ... of developing skin cancer, a number of states have ...
Cached Medicine News:Health News:R&J Public Relations Selected to Promote MAQUET Inc.'s VARIOP Operating Room Suite in North America 2Health News:Pharmaceutical Water Markets, the Economic Crunch Creates New Opportunities in Southern and Eastern Europe 2Health News:Cleveland Clinic Issues New Guide for Chronic Hip Pain 2Health News:Cleveland Clinic Issues New Guide for Chronic Hip Pain 3Health News:The St. John-Clark Pain Treatment Center Forms Manual Therapy 'Dream Team' 2Health News:Johnson Matthey Medical Announces Expansion 2Health News:State policies have little effect on reducing minors' indoor tanning use 2
... Testosterone is the most important androgen ... is secreted,primarily by the Leydig cells of ... circulating testosterone is derived from,peripheral conversion of ... ca. 25% from the adrenal glands. The ...
Microalbumin Turbidimetric Lipid / Protein Quantification 021-SDX001...
... an enzyme immunometric assay (EIA) in ... phase,incubation, designed for the quantitative measurement ... is coated,with anti-rabbit antibodies.,Calibrators and patient ... wells, along with rabbit anticortisol,antibodies and ...
Vitamin B6 Jumbo REA Vitamin Assays, Cardiovascular 001-RK-VB6N...
Medicine Products: